Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 28, 2024 03:00 ET | Source: Intravacc B.V.

Intravacc and Primrose Bio Announce Partnership to Enhance Conjugate Vaccine Development

Primrose Bio will supply its industry-leading carrier protein, PeliCRM197®, for vaccine developmentIntravacc has IP and know-how in vaccine conjugation and manufacturing of carrier protein based...
March 26, 2024 03:00 ET | Source: Intravacc B.V.

Intravacc announces positive data of first in human intranasal OMV based vaccine for SARS-CoV-2

First in human phase I clinical study using OMV as an adjuvant for intranasal vaccinationAvacc 10® intranasal booster vaccine induces a mucosal response and no adverse eventsData will be presented at...
January 16, 2024 06:00 ET | Source: Intravacc B.V.

Intravacc Awarded US$ 633K CARB-X Funding to Develop a Vaccine that Prevents Gonorrhea Infections

Intravacc secures $633K funding from CARB-X to develop a vaccine against or Neisseria gonorrhoeae.
December 20, 2023 06:10 ET | Source: Intravacc B.V.

Intravacc launches new website with a wealth of scientific knowledge to elevate vaccine innovation

Intravacc's new website offers an immersive user experience, showcasing their CDMO expertise vaccine platforms and a hub for scientific publications.
September 19, 2023 02:00 ET | Source: Intravacc B.V.

Intravacc announces publication of In Vitro alternative to replace animal pyrogen test for vaccines

Intravacc and Sanquin Diagnostic Services optimized the in vitro Monocyte Activation Test (MAT) for OMV vaccinesMAT test potential replacement for the traditional rabbit pyrogen testing (RPT) for...
September 14, 2023 02:00 ET | Source: Intravacc B.V.

Intravacc Announces Review Publication of OMV-based Intranasal Vaccines for Disease Prevention

Mucosal route induces both localized and systemic immunityIntravacc is currently developing 3 OMV-based intranasal vaccinesArticle published in peer-reviewed journal ‘Current Opinions in Immunology’ ...